Meeder Asset Management’s Omega Protein OME Stock Holding History

Meeder Asset Management’s Portfolio OME Stock Details OME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-773	Closed	-$14K	–	1847
2017 Q2	$14K	Buy	+773	New	+$14.4K	﹤0.01%	918

Other funds holding OME

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fondren Management Houston, Texas $16.9M AUM 5.82% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Meeder Asset Management's OME Position: Q3 2017 in Review

Meeder Asset Management sold out of Omega Protein (OME) in Q3 2017, closing a stake of 773 shares — an estimated $14K sold.

Meeder Asset Management first reported a position in OME in Q2 2017 and held it in 1 quarter. The position peaked at $14K in Q2 2017. 122 funds tracked by Wall St. Rank hold OME as of Q3 2017.

Meeder Asset Management reported no remaining Omega Protein position as of Q3 2017 after selling out during the quarter.
Meeder Asset Management sold 773 Omega Protein shares in Q3 2017, an estimated $14K.
Meeder Asset Management first reported a position in Omega Protein in Q2 2017 and held it in 1 quarter.
Meeder Asset Management's Omega Protein position peaked at $14K in Q2 2017.
122 funds tracked by Wall St. Rank held Omega Protein as of Q3 2017.

Based on Meeder Asset Management's 13F filing for Q3 2017, filed 20 Oct 2017.